About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Pharmacokinetics of Procaterol in Elite Athletes

NCT05749536·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Bispebjerg Hospital

Doping study

Age

18–45

Sex

MALE

Healthy volunteers

Accepted

You may be eligible if

Doctor diagnosed asthma for the asthmatic group
GINA 1-3 for the asthmatic group
Use of beta2-agonist for at least 12 months for the asthmatic group
age 18-45
males
informed consent

You may not be if

smoker or former smoker
airway infection to weeks prior to the study or during the study
other chronic diseaes than asthma and allergy
Use of beta2-agonist 6 days prior to the study
Allergy to the study medicine

The record

StatusCompleted

PhaseNo phase

Taking part20

StartedAug 2011

UpdatedMar 1, 2023

Conditions

Where1

Bispebjerg Hospital
Copenhagen, Denmark

Clareo Health | Pharmacokinetics of Procaterol in Elite Athletes